NBR subscribers weigh in on director's illness disclosure
In the age of social media, privacy can seem like a lost concept: IoD chief executive Simon Arcus.
A company should only disclose a director’s health issues once they become life-threatening, NBR subscribers believe.
There are no NZX listing rules that relate specifically to illness but a spokeswoman recommends if the medical matter affects the ability of the director or chief executive to
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Wed, 06 Jul 2016
Wed, 06 Jul 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
NBR subscribers weigh in on director's illness disclosure
59683